The White House has blamed the Biden administration for failing to advance domestic production or fill the reserve.

Sanofi's Tzield is now the first and only disease-modifying therapy to be approved for type 1 diabetes (T1D) in the UK.

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by the accumulation of scar tissue in the ...

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be ...

This podcast tackles how pharma can drive better commercial packaging collaborations during the transition from clinical to ...

According to the US Centers for Disease Control and Prevention, substance use disorder (SUD) affects approximately one in six people in the US.